Back to Atlas
APotentially durableStandard research/education caution
CMP-0069
Approved for specific indications in some regions
Melanotan I / Afamelanotide
Pigmentation
Melanin production and photoprotective pigmentation
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- MC1R agonism
- Primary market use
- Photoprotection / cosmetic
Pharmacology
- Molecular weight (Da)
- 1646.9
- Oral bioavailability
- N/A
- Half-life
- ~30 min; implant effect longer
- Route tags
- Route-dependent / verify
- Evidence level
- Approved/Clinical
- Clinical status
- Approved for specific indications in some regions
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Pigment changes can outlast drug exposure